CaMKII, 'jack of all trades' in inflammation during cardiac ischemia/reperfusion injury

J Mol Cell Cardiol. 2023 Nov:184:48-60. doi: 10.1016/j.yjmcc.2023.10.003. Epub 2023 Oct 7.

Abstract

Myocardial infarction and revascularization cause cardiac ischemia/reperfusion (I/R) injury featuring cardiomyocyte death and inflammation. The Ca2+/calmodulin dependent protein kinase II (CaMKII) family are serine/ threonine protein kinases that are involved in I/R injury. CaMKII exists in four different isoforms, α, β, γ, and δ. In the heart, CaMKII-δ is the predominant isoform,with multiple splicing variants, such as δB, δC and δ9. During I/R, elevated intracellular Ca2+ concentrations and reactive oxygen species activate CaMKII. In this review, we summarized the regulation and function of CaMKII in multiple cell types including cardiomyocytes, endothelial cells, and macrophages during I/R. We conclude that CaMKII mediates inflammation in the microenvironment of the myocardium, resulting in cell dysfunction, elevated inflammation, and cell death. However, different CaMKII-δ variants exhibit distinct or even opposite functions. Therefore, reagents/approaches that selectively target specific CaMKII isoforms and variants are needed for evaluating and counteracting the exact role of CaMKII in I/R injury and developing effective treatments against I/R injury.

Keywords: Calcium-calmodulin-dependent protein kinase type 2; Cardiac ischemia reperfusion injury; Cell death; Inflammation.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 / metabolism
  • Endothelial Cells / metabolism
  • Humans
  • Myocardial Infarction* / metabolism
  • Myocardial Reperfusion Injury* / metabolism
  • Myocytes, Cardiac / metabolism
  • Protein Isoforms / metabolism

Substances

  • Calcium-Calmodulin-Dependent Protein Kinase Type 2
  • Protein Isoforms